George Rho, Great Analyst Saying Shares Have Considerable Upside . Post.
Keryx: A Small Biotech With Many Catalysts
May 8 2013 By: George RHO
Considering Zerenex's efficacy, safety, and administration advantages, versus the three main rivals in the market, as well as its unique ability to provide iron benefits, Keryx's ferric citrate has the potential to become the leading phosphate binder in the world. We believe the shares still have considerable upside potential, to be realized in the quarters and years ahead